Correction to: Cancer Chemotherapy and Pharmacology (2021) 87:207–215 https://doi.org/10.1007/s00280-020-04188-9
In the original publication of the article, the affiliation were mistakenly disordered. The correct affiliation is as follows
Shuo Yu1,2, Yang Li2, Hui Ren2, Hong Zhou2, Qian Ning2, Xue Chen2, Tinghua Hu2, Lan Yang2
1Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710000, Shaanxi, China
2Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710000, Shaanxi, China
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yu, S., Li, Y., Ren, H. et al. Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1. Cancer Chemother Pharmacol 88, 563 (2021). https://doi.org/10.1007/s00280-021-04275-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-021-04275-5